OT Pharma Fund III, LLC is a private investment fund based in Boston, Massachusetts. According to its most recent Form D, filed Jul 21, 2020, it has sold $24,464,051 of interests to 58 investors since its first sale in Dec 2019. The minimum investment it accepts from an outside investor is $100,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include LLC Assure Fund Management II; Richard Thoms; LLC OT Management.
- Total raised
- $24,464,051Cumulative sales reported on Form D
- Investors
- 58
- First sale
- Dec 10, 2019
- Minimum investment
- $100,000
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- LLC Assure Fund Management II; Richard Thoms; LLC OT Management
- Latest Form D
- Jul 21, 2020
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Jul 21, 2020 | Form D/A (amendment) | $24,464,051 | 58 | SEC.gov ↗ |
| Jun 9, 2020 | Form D/A (amendment) | $24,214,051 | 57 | SEC.gov ↗ |
| May 12, 2020 | Form D/A (amendment) | $23,555,385 | 49 | SEC.gov ↗ |
| Dec 11, 2019 | Form D | $16,417,842 | 24 | SEC.gov ↗ |
4 Form D filings in the SEC's electronic records (2008 onward), the earliest on Dec 11, 2019. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Questions about OT Pharma Fund III, LLC
What is the minimum investment for OT Pharma Fund III, LLC?
According to its latest Form D, filed Jul 21, 2020, the minimum investment OT Pharma Fund III, LLC accepts from an outside investor is $100,000.
Who can invest in OT Pharma Fund III, LLC?
OT Pharma Fund III, LLC is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has OT Pharma Fund III, LLC raised?
OT Pharma Fund III, LLC reports $24,464,051 sold from 58 investors on its Form D filed Jul 21, 2020. This is cumulative sales since the offering began, not current assets or performance.
Where is OT Pharma Fund III, LLC based?
OT Pharma Fund III, LLC is based in Boston, Massachusetts.
When did OT Pharma Fund III, LLC launch?
OT Pharma Fund III, LLC reports its first sale in Dec 2019.
Size compared with every private investment fund
Raised more than 48% of the 538 private investment funds based in Massachusetts, and more than 53% of all 10,333 that report sales.
Other funds with the same team
More private investment funds in Boston
- Acadian U.S. Micro/Small-Cap Equity Portable Alpha Fund, LLC$1.7M
- NHIT: Core Plus Fixed Income Trust$4.2B
- Bain Capital Senior Loan Fund, L.P.$3.3B
- Acadian U.S. Managed Volatility Equity Fund, LLC$91.7M
- Acadian Emerging Markets Small-Cap Equity Fund, LLC$2.3B
- Acadian Emerging Markets Managed Volatility Equity Fund, LLC$664M